FARALLON CAPITAL MANAGEMENT LLC Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$12.4T
Holdings
91
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (91 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | AABAUSDALTABA INC | 27,607,317 | $2.0T | 16.44% | |
| 2 | SPYSPDR S&P 500 ETF TR | 4,264,500 | $1.2T | 9.68% | Put |
| 3 | CELGCELGENE CORP | 8,430,000 | $795.3B | 6.39% | |
| 4 | WABWABTEC CORP | 6,242,572 | $460.2B | 3.70% | |
| 5 | GOOGALPHABET INC | 292,328 | $343.0B | 2.76% | |
| 6 | —IHS MARKIT LTD | 6,107,546 | $332.1B | 2.67% | |
| 7 | BKNGBOOKING HLDGS INC | 184,982 | $322.8B | 2.59% | |
| 8 | IQVIQVIA HLDGS INC | 2,157,595 | $310.4B | 2.49% | |
| 9 | METAFACEBOOK INC | 1,829,173 | $304.9B | 2.45% | |
| 10 | TRUTRANSUNION | 4,317,846 | $288.6B | 2.32% | |
| 11 | CHTRCHARTER COMMUNICATIONS INC N | 806,938 | $279.9B | 2.25% | |
| 12 | VVISA INC | 1,610,679 | $251.6B | 2.02% | |
| 13 | FISFIDELITY NATL INFORMATION SV | 2,124,515 | $240.3B | 1.93% | |
| 14 | ELVANTHEM INC | 825,000 | $236.8B | 1.90% | |
| 15 | PLYAPLAYA HOTELS & RESORTS NV | 30,606,930 | $233.5B | 1.88% | |
| 16 | EFXEQUIFAX INC | 1,959,018 | $232.1B | 1.87% | |
| 17 | CTXSEURCITRIX SYS INC | 1,990,184 | $198.3B | 1.59% | |
| 18 | MSFTMICROSOFT CORP | 1,630,401 | $192.3B | 1.55% | |
| 19 | SPGIS&P GLOBAL INC | 911,551 | $191.9B | 1.54% | |
| 20 | EQIXEQUINIX INC | 416,759 | $188.9B | 1.52% | |
| 21 | GDGENERAL DYNAMICS CORP | 1,081,488 | $183.1B | 1.47% | |
| 22 | ASNDASCENDIS PHARMA A S | 1,500,000 | $176.6B | 1.42% | |
| 23 | SHWSHERWIN WILLIAMS CO | 384,163 | $165.5B | 1.33% | |
| 24 | SESEA LTD | 6,920,000 | $162.8B | 1.31% | |
| 25 | AZNASTRAZENECA PLC | 3,885,000 | $157.1B | 1.26% | |
| 26 | CICIGNA CORP NEW | 945,000 | $152.0B | 1.22% | |
| 27 | —GOLDCORP INC NEW | 12,960,000 | $148.3B | 1.19% | |
| 28 | ARRYEURARRAY BIOPHARMA INC | 5,500,000 | $134.1B | 1.08% | |
| 29 | —ARRIS INTERNATIONAL PLC | 3,745,000 | $118.4B | 0.95% | |
| 30 | —ZOGENIX INC | 2,050,500 | $112.8B | 0.91% | |
| 31 | XLRNACCELERON PHARMA INC | 2,375,000 | $110.6B | 0.89% | |
| 32 | LBTYBLIBERTY GLOBAL PLC | 4,308,106 | $104.3B | 0.84% | |
| 33 | —MYOKARDIA INC | 1,950,278 | $101.4B | 0.81% | |
| 34 | FOXFOX CORP | 2,807,431 | $100.7B | 0.81% | |
| 35 | LBTYBLIBERTY GLOBAL PLC | 3,949,553 | $98.4B | 0.79% | |
| 36 | SG7SAGE THERAPEUTICS INC | 600,000 | $95.4B | 0.77% | |
| 37 | ENTAENANTA PHARMACEUTICALS INC | 940,000 | $89.8B | 0.72% | |
| 38 | MRTXEURMIRATI THERAPEUTICS INC | 1,200,000 | $88.0B | 0.71% | |
| 39 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,500,000 | $79.4B | 0.64% | |
| 40 | SRPTSAREPTA THERAPEUTICS INC | 650,000 | $77.5B | 0.62% | |
| 41 | BABAALIBABA GROUP HLDG LTD | 415,000 | $75.7B | 0.61% | |
| 42 | EX9EXELIXIS INC | 3,000,000 | $71.4B | 0.57% | |
| 43 | AMRNAMARIN CORP PLC | 3,250,000 | $67.5B | 0.54% | |
| 44 | RETAEURREATA PHARMACEUTICALS INC | 750,000 | $64.1B | 0.52% | |
| 45 | GRFSGRIFOLS S A | 2,926,352 | $58.8B | 0.47% | |
| 46 | IOVAIOVANCE BIOTHERAPEUTICS INC | 5,725,000 | $54.4B | 0.44% | |
| 47 | NVCRNOVOCURE LTD | 1,050,000 | $50.6B | 0.41% | |
| 48 | FGENEURFIBROGEN INC | 915,579 | $49.8B | 0.40% | |
| 49 | DISDISNEY WALT CO | 440,000 | $48.9B | 0.39% | |
| 50 | NXPINXP SEMICONDUCTORS N V | 535,000 | $47.3B | 0.38% | |
| 51 | ALNYALNYLAM PHARMACEUTICALS INC | 500,000 | $46.7B | 0.38% | |
| 52 | FATEFATE THERAPEUTICS INC | 2,500,000 | $43.9B | 0.35% | |
| 53 | —RADIUS HEALTH INC | 2,043,149 | $40.7B | 0.33% | |
| 54 | —SINA CORP | 650,000 | $38.5B | 0.31% | |
| 55 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,920,609 | $35.2B | 0.28% | |
| 56 | CVSCVS HEALTH CORP | 625,000 | $33.7B | 0.27% | |
| 57 | RCREADY CAP CORP | 2,243,239 | $32.9B | 0.26% | |
| 58 | PTCTPTC THERAPEUTICS INC | 700,000 | $26.3B | 0.21% | |
| 59 | FOXAFOX CORP | 709,220 | $26.0B | 0.21% | |
| 60 | CRSPCRISPR THERAPEUTICS AG | 725,000 | $25.9B | 0.21% | |
| 61 | —STEMLINE THERAPEUTICS INC | 2,000,000 | $25.7B | 0.21% | |
| 62 | CDXSCODEXIS INC | 1,250,000 | $25.7B | 0.21% | |
| 63 | —ZYMEWORKS INC | 1,575,000 | $25.5B | 0.20% | |
| 64 | —PTC THERAPEUTICS INC | 24,130,000 | $24.7B | 0.20% | |
| 65 | —QUOTIENT LTD | 2,500,000 | $22.5B | 0.18% | |
| 66 | PTGXPROTAGONIST THERAPEUTICS INC | 1,790,000 | $22.5B | 0.18% | |
| 67 | CCXIEURCHEMOCENTRYX INC | 1,500,000 | $20.8B | 0.17% | |
| 68 | —AVROBIO INC | 900,000 | $19.8B | 0.16% | |
| 69 | —PROGENICS PHARMACEUTICALS IN | 4,200,820 | $19.5B | 0.16% | |
| 70 | VYGRVOYAGER THERAPEUTICS INC | 1,000,158 | $19.1B | 0.15% | |
| 71 | YB4PSAVARA INC | 2,425,000 | $17.9B | 0.14% | |
| 72 | —BEMIS CO INC | 316,160 | $17.5B | 0.14% | |
| 73 | —ZEALAND PHARMA A S | 948,700 | $16.1B | 0.13% | |
| 74 | CLVSEURCLOVIS ONCOLOGY INC | 600,000 | $14.9B | 0.12% | |
| 75 | CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC | 18,750,000 | $14.4B | 0.12% | |
| 76 | —CYCLERION THERAPEUTICS INC | 844,085 | $12.5B | 0.10% | |
| 77 | VSMEURVERSUM MATLS INC | 210,000 | $10.6B | 0.08% | |
| 78 | NSTGEURNANOSTRING TECHNOLOGIES INC | 400,000 | $9.6B | 0.08% | |
| 79 | VOYAVOYA FINL INC | 185,000 | $9.2B | 0.07% | |
| 80 | —SPRINT CORPORATION | 1,590,000 | $9.0B | 0.07% | |
| 81 | GOSSGOSSAMER BIO INC | 377,852 | $8.2B | 0.07% | |
| 82 | NVTA1EURINVITAE CORP | 300,000 | $7.0B | 0.06% | |
| 83 | —ZAFGEN INC | 1,800,000 | $4.9B | 0.04% | |
| 84 | —PFENEX INC | 600,000 | $3.7B | 0.03% | |
| 85 | DVAXDYNAVAX TECHNOLOGIES CORP | 500,000 | $3.7B | 0.03% | |
| 86 | SNYSANOFI | 6,827,805 | $3.1B | 0.02% | |
| 87 | —APTINYX INC | 670,000 | $2.7B | 0.02% | |
| 88 | ASMBASSEMBLY BIOSCIENCES INC | 100,000 | $2.0B | 0.02% | |
| 89 | —RADIUS HEALTH INC | 1,250,000 | $1.0B | 0.01% | |
| 90 | —TRANSLATE BIO INC | 100,000 | $1.0B | 0.01% | |
| 91 | GOLGBPGOL LINHAS AEREAS INTLG S A | 14,498 | $189.0M | 0.00% |